C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability.
about
Exploring the role of cancer stem cells in radioresistanceMolecular radiobiology: the state of the artThe EGFR polymorphism rs884419 is associated with freedom from recurrence in patients with resected prostate cancer.The epidermal growth factor receptor in malignant gliomas: pathogenesis and therapeutic implications.Feasibility of cetuximab and chemoradiotherapy combination in Chinese patients with unresectable stage III non-small cell lung cancer: a preliminary reportEpidermal growth factor receptor and its inhibition in radiotherapy: in vivo findings.Integrating radiotherapy with epidermal growth factor receptor antagonists and other molecular therapeutics for the treatment of head and neck cancer.The role of cetuximab in the treatment of squamous cell cancer of the head and neck.Mechanisms of disease: Radiosensitization by epidermal growth factor receptor inhibitors.Increased expression of pAKT is associated with radiation resistance in cervical cancer.Cetuximab in the treatment of head and neck cancer.Gene discovery in cervical cancer : towards diagnostic and therapeutic biomarkers.The status of targeted agents in the setting of neoadjuvant radiation therapy in locally advanced rectal cancers.Cetuximab reverses the Warburg effect by inhibiting HIF-1-regulated LDH-AMolecular therapy in head and neck oncology.Hsp90 Inhibitor Ganetespib Sensitizes Non-Small Cell Lung Cancer to Radiation but Has Variable Effects with Chemoradiation.Heterogeneity of tumour response to combined radiotherapy and EGFR inhibitors: differences between antibodies and TK inhibitors.Nuclear EGFR as novel therapeutic target: insights into nuclear translocation and function.A review of clinical trials of cetuximab combined with radiotherapy for non-small cell lung cancerLong-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/- cetuximab in oesophageal cancer.Molecular Targeting of Growth Factor Receptor Signaling in Radiation Oncology.Sensitisation of human lung adenocarcinoma A549 cells to radiotherapy by Nimotuzumab is associated with enhanced apoptosis and cell cycle arrest in the G2/M phase.Cetuximab may inhibit tumor growth and angiogenesis induced by ionizing radiation: a preclinical rationale for maintenance treatment after radiotherapyDifferential efficacy of combined therapy with radiation and AEE788 in high and low EGFR-expressing androgen-independent prostate tumor models.Augmentation of radiation response by panitumumab in models of upper aerodigestive tract cancerAnti-erbB receptor strategy as a gene therapeutic intervention to improve radiotherapy in malignant human tumours.Cetuximab in preoperative treatment of rectal cancer - term outcome of the XERT trial.Selective inhibition of the epidermal growth factor receptor tyrosine kinase by BIBX1382BS and the improvement of growth delay, but not local control, after fractionated irradiation in human FaDu squamous cell carcinoma in the nude mouse.Comparison between weekly cisplatin-enhanced radiotherapy and cetuximab-enhanced radiotherapy in locally advanced head and neck cancer: first retrospective study in Asian population.[Experimental tumor therapy].[Prognostic significance of changes of tumor epidermal growth factor receptor expression after neoadjuvant chemoradiation in patients with rectal adenocarcinoma].
P2860
Q28282037-A5FD6B15-CFC0-49EF-A852-82A703A11E00Q34124274-6834B5C8-CF07-4F5B-A799-3178FDB3A548Q34194320-904492F8-9647-4D1A-BACE-FCD0DBC19A01Q34610495-77D9A7CB-366D-487B-9C92-165B9149ABAAQ35538759-B8ECFC57-A6FB-484C-BF85-900B464BB7B9Q35552515-E304096A-7F12-4EB6-8EEC-9D86E4A1A3FAQ36175239-AC723B2C-B86F-49F7-B5D4-3605BFBA2F7EQ36210876-AE54E6D2-C110-4BB2-BF58-3B524BC9F85DQ36303867-6E83CE2E-938D-4394-A3BC-BD0F0B64C9BBQ36487722-43202B39-ABCD-4DC9-A4CB-CBF7AF4F00EDQ36668224-6DEF37A2-3091-4624-8771-1A8E2277D96CQ36982644-97166212-3FA8-4FA6-BBFE-6633991547F3Q37015715-68FA131C-8AC2-4438-B615-D73047047088Q37262663-9C4AD43C-A707-460A-9C58-5BF5D69E03EBQ37458175-F62469AA-5F56-492D-A221-3EFF72D285D8Q37470072-49F9269D-59DA-4F63-B9A5-7B57EE7EEA09Q37628728-BB2D40EB-2331-4CE2-97A1-200C5981F669Q37676970-F1601FF0-CDC0-42A5-9ED5-BB287CA011F0Q37975010-B5F9F802-B18F-4ADA-BB1E-161D874635B4Q38757690-6CBCE98A-B0AD-46D0-B57C-2350667ACACAQ38869420-6ED890EE-0BD6-4824-B714-CDA6ADF31F19Q38973520-3EE6A341-5FE4-4308-802F-776713B5C013Q39509472-225C9632-12B7-4ED9-BB80-31C1C81B2190Q39635478-32B8DCC8-D053-403B-9A9C-B4FF802D0041Q39939644-969110BE-B3BA-42BF-8F1E-DED398B049E1Q40628684-7F4484EC-9B40-43F2-8CFC-0A08CA3D25E2Q42423159-5B7FAB11-82EC-42FE-AB9A-88D02FDDBA52Q44608845-9A41F630-5429-47F4-B8BD-2E21815234D0Q51344874-336F3117-B306-4DD8-93DA-80712687EE62Q54490610-0389360A-7F71-4BBC-97EB-B6B85306221DQ54493763-58A0D549-7C1E-428A-838E-C7996FE193EE
P2860
C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability.
@en
C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability.
@nl
type
label
C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability.
@en
C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability.
@nl
prefLabel
C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability.
@en
C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability.
@nl
P2093
P1476
C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability.
@en
P2093
P304
P356
10.1016/S0360-3016(01)01671-6
P407
P577
2001-10-01T00:00:00Z